Veterinary Medicine Information website

Cazitel Plus Tablets for Dogs

Authorised
  • Praziquantel
  • Febantel
  • Pyrantel embonate

Product identification

Medicine name:
Cazitel Plus Tablets for Dogs
Active substance:
  • Praziquantel
  • Febantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/MRP/09/0029
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0243/001
Concerned member states:
  • Austria
  • Bulgaria
  • Cyprus
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 24/08/2025
Download
Latvian (PDF)
Published on: 12/02/2026

Summary of Product Characteristics

English (PDF)
Published on: 24/08/2025
Updated on: 13/03/2026
Download

ie-puar-mr-iev0243001-cazitel-plus-tablets-for-dogs-en.pdf

English (PDF)
Published on: 25/09/2024
Download